Too often, due to a complex combination of fear, stigma, financial, and family implications, individuals affected by devastating rare genetic conditions like Huntington’s disease have been marginalized and misunderstood. Today,… CONTINUE
Dawn Laney, MS, CGC, CCRC | ThinkGenetic Co-Founder
As a Co-Founder of ThinkGenetic, Inc., Dawn Laney is responsible for directing the inclusion of genetic disease information and making important connections to those in the genetic field. As a genetic counselor, assistant professor, and program leader at Emory University in the Department of Human Genetics, Laney received her master’s degree in medical genetics from the Sarah Lawrence College in 1999. She received her certification from the American Board of Genetic Counseling in 2002. Since joining the Emory Division of Medical Genetics in 2002, Laney has been involved in follow-up of abnormal metabolic newborn screening for the state of Georgia, development and management of a genetic infusion center, and lysosomal storage disease clinical care and research. She is currently the program leader for the Emory Lysosomal Storage disease center and director of the Emory Genetic Clinicial Trial Center. She serves on the Emory biomedical IRB committee. Laney is the primary instructor/coordinator for the Developmental Biology and Human Malformation course at Emory University. In 2016 she was awarded an NORD Rare Impact Honoree. She has published six books providing genetic condition information to kids and their families.
About Dawn Jacob Laney
As a Co-Founder of ThinkGenetic, Inc., Dawn Laney is responsible for directing the inclusion of genetic disease information and making important connections to those in the genetic field. As a genetic counselor, assistant professor, and program leader at Emory University in the Department of Human Genetics, Laney received her master’s degree in medical genetics from the Sarah Lawrence College in 1999. She received her certification from the American Board of Genetic Counseling in 2002. Since joining the Emory Division of Medical Genetics in 2002, Laney has been involved in follow-up of abnormal metabolic newborn screening for the state of Georgia, development and management of a genetic infusion center, and lysosomal storage disease clinical care and research. She is currently the program leader for the Emory Lysosomal Storage disease center and director of the Emory Genetic Clinicial Trial Center. She serves on the Emory biomedical IRB committee. Laney is the primary instructor/coordinator for the Developmental Biology and Human Malformation course at Emory University. In 2016 she was awarded an NORD Rare Impact Honoree. She has published six books providing genetic condition information to kids and their families.